Suppr超能文献

人体关键部位与人体相关的微生物群落的人际间和个体内多样性。

The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites.

机构信息

Department of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, CO, USA.

出版信息

J Allergy Clin Immunol. 2012 May;129(5):1204-8. doi: 10.1016/j.jaci.2012.03.010.

Abstract

The human body harbors 10 to 100 trillion microbes, mainly bacteria in our gut, which greatly outnumber our own human cells. This bacterial assemblage, referred to as the human microbiota, plays a fundamental role in our well-being. Deviations from healthy microbial compositions (dysbiosis) have been linked with important human diseases, including inflammation-linked disorders, such as allergies, obesity, and inflammatory bowel disease. Characterizing the temporal variations and community membership of the healthy human microbiome is critical to accurately identify the significant deviations from normality that could be associated with disease states. However, the diversity of the human microbiome varies between body sites, between patients, and over time. Environmental differences have also been shown to play a role in shaping the human microbiome in different cultures, requiring that the healthy human microbiome be characterized across life spans, ethnicities, nationalities, cultures, and geographic locales. In this article we summarize our knowledge on the microbial composition of the 5 best-characterized body sites (gut, skin, oral, airways, and vagina), focusing on interpersonal and intrapersonal variations and our current understanding of the sources of this variation.

摘要

人体中栖息着 10 到 100 万亿的微生物,主要是肠道内的细菌,其数量远远超过我们人类自身的细胞数量。这种细菌集合体被称为人类微生物组,它在我们的健康中起着至关重要的作用。偏离健康微生物组成(失调)与重要的人类疾病有关,包括与炎症相关的疾病,如过敏、肥胖和炎症性肠病。描述健康人类微生物组的时间变化和群落成员对于准确识别可能与疾病状态相关的显著偏离正常情况至关重要。然而,人体微生物组的多样性在不同的身体部位、不同的患者和不同的时间之间存在差异。环境差异也被证明会在不同的文化中影响人类微生物组的形成,因此需要在不同的年龄段、种族、国籍、文化和地理位置来描述健康的人类微生物组。在本文中,我们总结了对 5 个最佳特征化身体部位(肠道、皮肤、口腔、呼吸道和阴道)的微生物组成的了解,重点关注人际间和个体内的变化以及我们对这种变化来源的理解。

相似文献

1
The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites.
J Allergy Clin Immunol. 2012 May;129(5):1204-8. doi: 10.1016/j.jaci.2012.03.010.
2
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
3
Microbiome and skin diseases.
Curr Opin Allergy Clin Immunol. 2013 Oct;13(5):514-20. doi: 10.1097/ACI.0b013e328364ebeb.
4
Gut matters: microbe-host interactions in allergic diseases.
J Allergy Clin Immunol. 2012 Jun;129(6):1452-9. doi: 10.1016/j.jaci.2011.12.993. Epub 2012 Feb 8.
5
The microbiome in inflammatory bowel disease: current status and the future ahead.
Gastroenterology. 2014 May;146(6):1489-99. doi: 10.1053/j.gastro.2014.02.009. Epub 2014 Feb 19.
6
Microbiota regulation of inflammatory bowel disease.
Inflamm Allergy Drug Targets. 2014 Feb;13(1):65-73. doi: 10.2174/1871528113666140118202140.
7
The role of the microbiome in gastrointestinal inflammation.
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20203850.
8
Effect of barrier microbes on organ-based inflammation.
J Allergy Clin Immunol. 2013 Jun;131(6):1465-78. doi: 10.1016/j.jaci.2013.04.031.
9
Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.
World J Gastroenterol. 2014 Nov 28;20(44):16498-517. doi: 10.3748/wjg.v20.i44.16498.
10
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
World J Gastroenterol. 2015 Oct 28;21(40):11321-30. doi: 10.3748/wjg.v21.i40.11321.

引用本文的文献

1
Bridging traditional Chinese medicine and Alzheimer's disease: the pivotal role of gut microbiota in multitarget therapeutic mechanisms.
Front Pharmacol. 2025 Jun 27;16:1630205. doi: 10.3389/fphar.2025.1630205. eCollection 2025.
2
Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis.
NPJ Biofilms Microbiomes. 2025 Jul 1;11(1):115. doi: 10.1038/s41522-025-00748-0.
3
Cyclodextrins as Modulators of Gut Microbiota: Pharmaceutical Applications and Impact on Intestinal Health.
Pharmaceutics. 2025 Jun 7;17(6):752. doi: 10.3390/pharmaceutics17060752.
4
Assessing the health of the gut microbial organ: why and how?
J Clin Invest. 2025 Jun 2;135(11). doi: 10.1172/JCI184313.
7
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin.
Pharmaceuticals (Basel). 2025 Jan 6;18(1):55. doi: 10.3390/ph18010055.

本文引用的文献

1
Bacterial biogeography of the human digestive tract.
Sci Rep. 2011;1:170. doi: 10.1038/srep00170. Epub 2011 Nov 25.
2
The intestinal microbiota in health and disease.
Curr Opin Gastroenterol. 2012 Jan;28(1):63-9. doi: 10.1097/MOG.0b013e32834d61e9.
3
The intestinal microbiota and obesity.
J Clin Gastroenterol. 2012 Jan;46(1):16-24. doi: 10.1097/MCG.0b013e31823711fd.
4
The Human Microbiome Project in 2011 and beyond.
Cell Host Microbe. 2011 Oct 20;10(4):287-91. doi: 10.1016/j.chom.2011.10.001.
5
Obesity and the gut microbiota.
J Clin Gastroenterol. 2011 Nov;45 Suppl:S128-32. doi: 10.1097/MCG.0b013e31821f44c4.
6
Linking long-term dietary patterns with gut microbial enterotypes.
Science. 2011 Oct 7;334(6052):105-8. doi: 10.1126/science.1208344. Epub 2011 Sep 1.
7
Comparison of the gut microbiotas of healthy adult twins living in South Korea and the United States.
Appl Environ Microbiol. 2011 Oct;77(20):7433-7. doi: 10.1128/AEM.05490-11. Epub 2011 Aug 26.
8
Spatial distribution of microbial communities in the cystic fibrosis lung.
ISME J. 2012 Feb;6(2):471-4. doi: 10.1038/ismej.2011.104. Epub 2011 Jul 28.
9
Moving pictures of the human microbiome.
Genome Biol. 2011;12(5):R50. doi: 10.1186/gb-2011-12-5-r50.
10
Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans.
Science. 2011 May 20;332(6032):970-4. doi: 10.1126/science.1198719.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验